Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132048) titled 'A clinical efficacy study of Bezafibrate in the treatment of diminished ovarian reserve' on Sept. 9.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Zhongshan Hospital, Fudan University
Condition:
Diminished ovarian reserve
Intervention:
Experimental group:High-dose: Take bezafibrate orally three times a day, 0.4g each time
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-09
Target Sample Size: Experimental group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=335793
Published by HT Di...